Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Vail

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Veterinary and Comparative Oncology|November 14, 2014
Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcomaM B J Kung, V J Poirier, M M Dennis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine modelD M Vail, R Chun, D H Thamm, et al.
Veterinary and Comparative Oncology|January 13, 2012
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding studyC Robat, C London, L Bunting, et al.
Journal of Veterinary Internal Medicine|January 1, 1990
Alterations in carbohydrate metabolism in canine lymphomaD M Vail, G K Ogilvie, S L Wheeler, et al.
Radiation Oncology Investigations|July 4, 1998
Computed tomographic evaluation of radiation pneumonitis in a canine modelL J Forrest, P A Mahler, D M Vail, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a modelD M Vail, A A Elfarra, A J Cooley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanomaS A Soergel, E G MacEwen, D M Vail, et al.
Journal of Veterinary Internal Medicine|October 3, 2014
Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphomaM A Morges, J H Burton, C F Saba, et al.
Veterinary and Comparative Oncology|May 16, 2013
Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell linesJ A Lawrence, M K Huelsmeyer, D H Thamm, et al.
Veterinary and Comparative Oncology|May 6, 2016
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding studyM A Pellin, R M Wouda, K Robinson, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Veterinary and Comparative Oncology|November 14, 2014
Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcomaM B J Kung, V J Poirier, M M Dennis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine modelD M Vail, R Chun, D H Thamm, et al.
Veterinary and Comparative Oncology|January 13, 2012
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding studyC Robat, C London, L Bunting, et al.
Journal of Veterinary Internal Medicine|January 1, 1990
Alterations in carbohydrate metabolism in canine lymphomaD M Vail, G K Ogilvie, S L Wheeler, et al.
Radiation Oncology Investigations|July 4, 1998
Computed tomographic evaluation of radiation pneumonitis in a canine modelL J Forrest, P A Mahler, D M Vail, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a modelD M Vail, A A Elfarra, A J Cooley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanomaS A Soergel, E G MacEwen, D M Vail, et al.
Journal of Veterinary Internal Medicine|October 3, 2014
Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphomaM A Morges, J H Burton, C F Saba, et al.
Veterinary and Comparative Oncology|May 16, 2013
Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell linesJ A Lawrence, M K Huelsmeyer, D H Thamm, et al.
Veterinary and Comparative Oncology|May 6, 2016
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding studyM A Pellin, R M Wouda, K Robinson, et al.
Pageof 8